🇯🇵
COUNTRY FEED
Clinical Trials in Japan
Active recruiting clinical trials with sites in Japan. Select a condition below to see detailed trial listings.
Total Trials: 72 // Recruiting: 72 // Updated: Daily
Japan currently has 72 clinical trials with at least one registered site in the country, of which 72 are actively recruiting participants. The most studied conditions at Japan sites are Solid Tumors, Breast Cancer, Gastric Adenocarcinoma, reflecting where local investigators and sponsors are concentrating enrolment.
Studies are led by sponsors including Novartis Pharmaceuticals, Pfizer, Daiichi Sankyo. By stage, active Japan trials break down as Phase 1 (20), Phase 2 (17), Phase 3 (18), Phase 4 (4). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.
Top Conditions in Japan
Solid Tumors 6 Breast Cancer 3 Gastric Adenocarcinoma 2 Solid Tumor 2 Obesity 2 Pulmonary Arterial Hypertension 1 Crohn Disease 1 Perianal Fistula 1 Perianal Fistula Due to Crohn's Disease 1 Perianal Crohn's Disease 1 Ovarian Endometrioma 1 Endometriosis 1 Pancreatic Fluid Collection 1 Walled-off Necrosis 1 Pancreatitis, Acute Necrotizing 1 Pancreatic Pseudocyst 1 Neoplasms 1 Mandibular Reconstruction 1 Segmental Mandibular Defects 1 Radiation Exposure 1
Other Countries in This Region
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology